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Abstract: 
Bisphenol A (BP A) is commonly used to make plastics, and it is also used to make epoxy 
resin linings for metal food containers. People are exposed to this chemical daily through bottles, 
metal food containers, and other plastic products. BP A exposure has been linked to negative 
effects on the body including cardiovascular diseases, diabetes, and reproductive problems. 
Special caution should be taken for children because their systems are not fully developed, and 
they are often more susceptible to the negative effects. BP A can bind to estrogen receptors and 
activate them. It has this ability because of structural similarities to estradiol (Figure 1 ). 
Bisphenol A 
CH3 
I 
C 0 OH 
I OH 
CH3 
Figure 1. Chemical Structures of BPA (left) and Estradiol (right). 
Both compounds contain a phenol group, which can react with estrogen receptors. 
While BP A is now regulated in many plastic products, it is not regulated in toothbrushes. 
This summer's research tested for BPA in several infant oral hygeine products. BPA is a 
fluorescent compound with an excitation wavelength of 277 nm and an emission wavelength of 
304 nm. The presence ofBPA was determined through the use ofthe FS-5 Spectrofluorometer 
from Edinburgh Intruments. A calibration curve and analytical figures of merit (linear range, 
limit of detection, and limit of quantitation) were determined for BP A. This information was 
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then utilized to monitor the concentrations of BP A that leached from several brands of infant 
toothbrushes over time. Products labeled as "BP A free" were compared to products that did not 
have a corresponding label. 
Introduction: 
BPA, or bisphenol-A, is a chemical that is used in 
the manufacturing of plastics, linings of cans, and many 
other products. Although it is a component in many items, it 
has been found to have negative effects on the human body. 
The first signs ofBPA toxicity were founded in the 1930's. 
When first discovered, BP A was used as a pharmaceutical hormone replacement. The chemical 
industry first started using it in plastics around the 1940's, which is how it was commonly used, 
even today. However, the first law to regulate BPA was not made until1976. The topic of 
whether BP A is harmful has been a widely debated issue. i The evidence of the regulation can be 
seen in the commonly seen "BP A free" labels on items like water bottles, plastic containers, and 
other items. It is not commonly found on most popular infant toothbrushes. 
The negative effects of BP A are because it is and endocrine disrupter. An endocrine 
disrupter has a similar structure to the hormone that it is interfering with. Because of the 
structural similarities, the endocrine disrupter can bind to the hormone binding sites. This leads 
to the "turning on" of pathways that are not supposed to be started and inhibiting the normal 
function of the hormone (Figure 2). BP A specifically disrupts the regulation of the hormone 
estrogen (estradiol). ii BP A is capable of causing this disruption because it has a group that 
resembles a group on estrogen, and that makes it able to bind to the same type of endocrine 
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receptors. Some ofthe negative effects ofthe BPA binding to the estrogen receptors are: male 
and female infertility, premature puberty, breast and prostate tumors, polycystic ovarian 
syndrome, type 2 diabetes, and fetal brain development. iii Infants and young children are 
especially susceptible to the negative effects of BP A. The susceptibility makes it especially 
important to study the products that infants and young children are using. iv 
1 
Response Response 
Figure 2. A hormone binds to the receptor and causes a response. However, and endocrine disruptor can 
bind to the receptor due to structural similarities and cause the same response. This could also lead to the 
inhibition of a response. 
BP A in infant oral hygiene products is not a widely researched topic and the presence of 
BP A in the toothbrushes is not highly regulated. When looking at the "big name" brands of 
infant toothbrushes, it is not clearly labeled whether the product is BPA free or not. For my 
thesis research project, the presence of BP A in different oral hygiene products was investigated. 
BP A was present in different brands of infant toothbrushes. This information will help arm 
parents and guardians with information so they can avoid exposing their children to BP A. 
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Negative Health Effects ofBisphenol-A: 
To better understand the negative health effects ofBPA, it is important to look at the 
pathways that BP A interrupts or starts. As previously mentioned, BP A is an endocrine disrupter 
for the estrogen hormone (estradiol). BP A is found in many polycarbonate plastics and is used in 
food and drink packaging, water and infant bottles, compact disc, impact resistant safety 
equipment, and medical devices. Most exposure to BPA occurs through the diet.v Most ofthe 
exposure in the diet comes from the containers 
Estradiol 
BPA 
MBP 
Figure 3. Estradiol, BP A, and MBP, the 
metabolite of BP A. 
that the food is stored in, such as plastic 
containers or the lining of cans. The BP A 
leeches out of those containers and ultimately, 
we consume the leeched BP A in the food or 
liquid that is stored in the containers. There has 
been a lot of evidence showing that BP A has an 
impact even at low doses. vi BPA is 
metabolized in the body and that metabolite 
binds to the estrogen receptor more strongly 
than BP A itself. The metabolite is called 
methyl-bis-pentene (MPB) and is shown in 
Figure 3.vii 
As mentioned above, Bisphenol A mainly enters into the body through our diet; however, 
it can enter though dust, water, and air as well. v When BP A enters the body it can cause 
negative effects, such as diabetes, cardiovascular diseases, and female infertility, which will be 
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discussed later in detail. The negative health effects that are caused by BP A are especially 
harmful for children. They are growing and developing and hormones play an important role in 
developing. BP A would potentially disrupt the normal developing because it endocrine disrupter. 
According to Normiri and Ambrosino, there have been several studies that show that 
BP A is linked to many chronic health conditions. BP A deregulates cell signaling pathways 
associated with cell growth, proliferation, migration, invasion, and apoptosis. This is what can 
BPA 
Bax...---- l ------.Bcl-2 
'\.mitochondrion/ 
...---- ~ 
damaged electron Increased membrane 
respiratolry chain :;::;:::c 
release 
~ ATP depletion .,. _________ apoptosome 
1 active crspase-3 
impaired GSIS apoptosls 
~ l~fmass 
~-cells dysfunction 
~ 
type 2 diabetes 
Figure 4. BP A can bind to estrogen receptors and 
cause apoptosis or A TP depletion. Both eventually 
lead to the dysfunction of the B-cells and ultimately 
type 2 diabetes. This is a proposed pathway. 
lead to the cancerous effects of BP A. 
BPA has specifically been linked to 
diabetes. The potential link between 
BP A exposure and type 2 diabetes and 
insulin resistance have been something 
that several researchers are studying. A 
study from 2013 suggests that BP A 
exposure is related to B-cell 
dysfunction. In this study, they tested 
the effect of BP A on INS-1 cells. INS-
1 cells are insulin secreting cells, and 
therefore, linked to diabetes. viii, ix 
They found that when exposed to BP A 
INS-1 cell viability is decreased. 
The study described above also found that BP A induces mitochondrial dysfunction in 
INS-1 cells. The mitochondria are a crucial part ofthe cell. The mitochondrion is involved in 
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many functions of the cell, such as signaling, cellular differentiation, and cell death. It also plays 
a large role in the cell cycle and cell growth. The mitochondrion has been referred to as the 
"powerhouse of the cell". It got this nickname because it supplies cellular energy.x They also 
found that BP A triggers apoptosis and the release of apoptogenic factors in INS-I cells. This 
happens when BPA is in high concentrations. Finally, this study found that BPA triggers 
apoptosis through the intrinsic mitochondrial pathway. The proposed pathway ofhow BPA 
induces B-cells dysfunction is shown below in Figure 1. In this figure, it is shown that BP A is 
affecting the Mitochondria and leading to apoptosis or A TP depletion which in tum leads to the 
dysfunction of the B-cells and ultimately type 2 diabetes. The article attempts to demonstrate the 
link between BPA and type 2 diabetes, but as of right now this is a theoretical pathway. ix 
The next serious condition that has been linked to BP A exposure is cardiovascular 
disease. Cardiovascular disease is a widely-studied health problem that affects individuals 
around the world. Researchers have analyzed the genetic, physiological, and pathophysiological 
causes of cardiovascular disease. However, the effects of different chemicals on the 
cardiovascular system need to be investigated further. One article suggests that the linkage 
between cardiovascular disease and BP A exposure is the ability of BP A to alter the cardiac Ca2+ 
handling, ion channel inhibition/activation, oxidative stress, and genome modifications. It has 
specifically been linked to angina, hypertension, heart attack, and coronary and peripheral 
arterial disease. High BP A urinary output has also been linked to arrhythmias and atherosclerosis 
in rodents.xi 
The final negative health effects linked to BP A are reproductive issues, the literature 
review for this project focused on female infertility. Female infertility has been defined as a 
failure to achieve a successful pregnancy after 12 months or more of appropriate, timed 
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unprotected intercourse. xii It has been found to affect 10-15% of couples. xiii Since BP A is an 
endocrine disruptor for the hormone estrogen, the link between female infertility and BP A 
exposure is not shocking. BPA can interfere with the endocrine system in the female body. It 
would in tum throw off the hormone balance in the female system. It has actually been found 
that BPA can accumulate in reproductive organs.xiv, xv 
BP A can cause functional defects in the hypothalamic system. The hypothalamic system 
is the link between the nervous system and the endocrine system through the pituitary gland. 
This could potentially result in the inability to reach reproductive capacity at the time of puberty. 
This would also lead to issues in maintaining that capacity during adulthood. There has been no 
definite pathway found for this effect. However, an article mentioned that is could be from the 
production ofkisspeptin. Kisspeptin is a driving signal of gonadotropin release hormone 
secretion. xii This hormone makes the pituitary gland produce and secrete hormones that cause 
the ovaries to make estrogen and progesterone. xvi 
BP A can also affect the ovaries. It has been linked to follicle loss. Decreased oocyte 
survival has also been linked to the exposure ofBPA to the body. BPA could also be linked to 
polycystic ovary syndrome. The symptoms of PCOS include hair loss, oily skin, infertility, 
weight gain, menstrual problems, and depression. xvii It affects 1 in 10 women of childbearing 
age. Women who have this disease have a hormonal imbalance. xviii This hormonal imbalance 
could potentially be linked to BP A exposure, since BPA has been found to cause hormonal 
imbalances. Research has shown that women with PCOS had a higher BP A level than those 
without PCOS. BP A has also been linked to an increase in testosterone concentration. xii 
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Fluorescence Spectrophotometry: 
BP A is a fluorescent compound, which means that it will experience excitation. 
Following the excitation, BPA will emit radiation. e ------- Excited State 
Energy is absorbed, and this is what ultimately leads to 
fluorescence (Figure 5). The excitation wavelength for 
BPA is around 278nm and the emission 
Absorption of 
light/photon 
('Excitation') 
~ 
wavelength is around 305 nm (Figure 6). _______ _. ____ ~--~.-----
Once the emission wavelength is recorded, 
Figure 5. This shows the absorption of light 
(excitation) and the emission of the fluorescent 
properties. 
it can be converted to the corresponding 
concentration of BP A that is in the M/W sample. Fluorescence can be used to detect small 
amounts of a substance and small molecules. In this experiment, the FS-5 Spectrofluorometer 
from Edinburg Instruments was used to detect the emission and excitation of the M/W solution 
that was being tested. 
Figure 6. The results from the FS-5 Spectrofluorometer. The excitation 
wavelength is on the left (around 278nm) and the emission wavelength 
is see on the right (around 305nm) 
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Materials and Methods: 
Materials: 
• 0052g of BP A 
• 50 mL ofHPLC grade water 
• 50mL of HPLC grade methanol 
• 1 OOmL volumetric flask 
• 25mL volumetric flasks 
• FS-5 Spectrofluorometer 
• A variety of toothbrushes 
• 14 5mL volumetric flasks 
• Glass micropipettes 
• Plastic micropipettes 
• 1 OOmL of HPLC grade methanol 
• 1 OOmL of HPLC grade water 
• 1 OOmL beaker 
• Goggles 
• Gloves 
• Labeling materials 
• 1 0% Nitric acid 
• 12 toothbrushes (BPA free and 
unlabeled) 
Toothbrushes Label 
Tested 
Red Firefly Not labeled 
Pink and Yell ow Not labeled 
Rexall 
Colgate Not labeled 
Colgate Not labeled 
Baby's First BP A free label 
Toothbrush 
Blue Firefly Not labeled 
Green Rexall Not labeled 
Jordan Super Soft BP A free label 
Orange Reach Not labeled 
Blue Totz Radius BP A free label 
Oral-B Not labeled 
Jordan Super Soft BP A free label 
In preparing for the calibration 
curve, 0.0052 g of BP A was weighed and 
put in a 1 OOmL volumetric flask and 
diluted to the mark with 50% 
methanol/water solution (M/W). The 
solution was then mixed together by 
shaking and swirling. The resulting 
solution concentration was 0.052 mg/mL. This stock solution was used to obtain a fluorescence 
calibration curve. Different mL volumes of the stock solution were removed and put in 25mL 
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volumetric flasks. The flasks were then filled to the 25mL 
line with 50% methanol water and the new solutions were 
run in the FS-5 Spectrofluorometer. A calibration curve 
was then prepared using the intensity values obtained from 
running the samples. The calibration curve was used to 
formulate the equation that was needed to find the 
concentration of BP A in each of the samples that were run 
later in the experiment. The calibration curve and data 
will be discussed in the next section. 
For this experiment, different brands of 
toothbrushes were tested for the presence of BP A. The 
toothbrushes were then 
labeled A-Lto keep the 
brands of the various 
toothbrushes anonymous 
and remove potential bias. 
After obtaining and labeling 
the toothbrushes, the 
presence of a BP A free label 
or not was recorded. The 
toothbrushes were then 
placed in a beaker with 1 00 mL of the methanol water solution. In this experiment, one 
toothbrush was tested per day. A timer was set and a 5mL sample was taken at 0 minutes, 5 
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minutes, 1 0 minutes, 15 minutes, 20 minutes, 40 minutes, 60 minutes, 80 minutes, 1 00 minutes, 
120 minutes, 4 hours, 5 hours, 6 hours, 24 hours, 48 hours, and 1 week after the toothbrush was 
placed in the solution. These solutions were then run in the FS-5 Spectrofluorometer during the 
large gaps of time throughout the day. The emission intensity, emission wavelength, excitation 
intensity, and the excitation wavelength were recorded for each sample collected. 
Using the equation from the calibration curve, the intensities were then converted to 
concentration of BP A. The analytical figures of merit were calculated and used to determine if 
BP A had in fact leeched from the toothbrushes into the solution. All of this information was 
graphed using Microsoft Excel, and the toothbrushes with BP A free labels were compared to 
toothbrushes without BP A free labels. 
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Results and Discussion: 
At the beginning of the experiment, samples were run and a calibration curve was made 
with the solutions that had a fixed concentration of BP A. The calibration curve is shown below 
in Figure 7. The equation from the calibration curve was used to calculate the concentrations are 
later seen in Table I. 
1.80£+06 
1.60£+06 
1.40£+06 
1.20£+06 
>-t: 1.00£+06 
r:/J 
;z: 
u.J 
~ 8.00£+05 
6.00£+05 
4.00£+05 
2.00£+05 
O.OOE+OO 
0 
CALIBRATION CURVE 
y= 8E+07x 
R' = 0.9671 
• 
• 
• • 
• 
• 
• 
• 
0.005 0.01 0.015 0.02 
CONCENTRATION (MG/ML) 
Figure 7. Fluorescence Emission Calibration Curve 
For BPA in 1:1 M/W at 308nm 
0.025 
As discussed in the materials and methods section ... experiment reminder. Monitoring 
the release of BP A from toothbrushes into your M/W over time. 
After the experiment, the emission intensities were recorded and converted to 
concentration of BP A in those samples using the relationship between concentration and 
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::::J 
intensity found in the calibration curve (Figure 7). The results of this conversion are shown on 
the next page in Table I. The table also includes ifthe toothbrushes were labeled as BPA free. 
The concentrations were then graphed in Microsoft Excel. Appendix A shows the graphs 
for all of the toothbrushes tested. The graphs were then used to compare the concentrations of 
toothbrushes labeled BP A free and those not labeled BP A free. In each example graph below, the 
concentrations of BP A leached from two toothbrushes over time were compared. In Figure 8, 
Toothbrush E was labeled BPA free, and toothbrush C was not labeled BPA free. The same 
pattern was followed in Figure 9 where H and K were compared. The results are shown below. 
Comparing toothbrush C and E 
6.00E-04 
Comparing toothbrush H and K 
6.00E-04 
5.00E-04 • 
······ .... 
... 
······· 
• 
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···· · 
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.....J • 
• 
········ .. ..... 
E 4.00E-04 ... 
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E 4.00E-04 
On ··· ·· .... 
····· 
On .· 
E 
'--' 
§ 3.00E-04 _. . · .. • e 
~ 2.00£-W ,~ ••.• -· . • 
I.OOE-04 
O.OOE+OO 
0 500 1000 1500 2000 2500 3000 3500 
time (min) 
• c e E 
Figure 8. Toothbrush E has the BPA free label, and it is being 
;ompared to toothbrush C which has no BPA free label. 
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u § 2.00E-04 
u 
I.OOE-04 
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Time (min) 
e sample H • sample K 
Figure 9. Toothbrush H has the BPA free label, and it is being 
compared to toothbrush K which has no BPA free label. 
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As shown in the figures above (figures 8 & 9), the toothbrushes that were labeled as BPA 
free (E and H) released little to no BPA into the methanol water over a period oftime. However, 
the toothbrushes shown in the graphs that were not labeled BP A free (C and K) did show an 
increase in the amount of BP A released into the methanol water over a period of time. 
T-tests were performed comparing the toothbrushes in the above graphs (C, E, H, and K) 
and it was found that the toothbrushes without a BP A free label (E and H) had a statistically 
significant difference in concentrations when compared to the toothbrushes that were labeled 
BP A free. The changes in concentration of BP A leached into methanol water over time from all 
of the toothbrushes are summarized in Table I below. The rows that are white (E, H, and J) were 
labeled BP A free and contained little to no BP A. The rows that are light purple (F, G, and I) also 
remained low, which indicates that they may also be BP A free. The rows that are dark purple (B, 
C, D, and K) had a significant increase in BP A concentration, that was statistically significantly 
different that the lower concentrations, which suggest that these toothbrushes do contain BP A. 
Table I. Concentration of BP A leaching from toothbrushes in 1: 1 M/W over time 
: Not labeled and higher concentration. 
Lighter purple: Not labeled and lower concentration 
White: Labeled as BP A free 
Toothbrush Label on 
BPA free 
No label 
J BPA free 
Concentration at 0 
hours (mg/ml) 
.000208 
.000195 
Concentration at 6 
hours (mg/ml) 
.000238 
.000254 
.000233 
.000179 
.0 73 
.000222 
Concentration at 
24 hours (mg/ml) 
.000213 
.000267 
K No label .000172 .000302 .000446 
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Conclusions: 
In examining the results of this study, it can be concluded that M/W exposed to 
toothbrushes with BP A free label have a statistically significantly lower concentration at a 95% 
confidence level than M/W exposed to the toothbrushes that are not labeled BP A free. A 
significant increase is seen specifically in toothbrushes B, C, D, and K. The higher 
concentrations indicate that BPA may be present. Toothbrushes not labeled BPA free that had a 
lower concentration could be toothbrushes that are not labeled, but that do not contain BP A. The 
lower concentration toothbrushes are seen in toothbrushes F, H, and J, which are the ones with 
the "BPA free" label. There is still work to do to quantify the amount ofBPA present in the 
toothbrushes. This is a valid method for the determination of the presence of BP A in 
toothbrushes because we were able to differentiate between the sample sets. 
Future Experiments: 
In the future, it would be useful to examine toothbrushes at different pH values. This 
could mimic the different pHs that the toothbrushes could potentially be exposed to. It would 
also be helpful to test the toothbrushes at different temperatures. This would mimic the different 
temperatures that the toothbrushes would be exposed to throughout their existence. They could 
be exposed to extreme temperatures in the warehouse, the delivery trucks, or even sitting in the 
sun in the bathroom. These different scenarios are very important to consider, so an accurate 
measure of the presence of BP A can be obtained. The brushing motion that the toothbrush is put 
under while individuals brush their teeth needs to be researched as well. Theoretically, this could 
make a difference in the amount of potential BP A that is leeched off from the toothbrush into 
children's vulnerable bodies. Finally, like any experiment, this experiment needs to be repeated 
to ensure the results that were obtained in this experiment were valid and reproducible. 
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